{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:03Z","timestamp":1793035863546,"version":"4.5.0"},"reference-count":27,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,5,25]]},"DOI":"10.1253\/circj.cj-26-0119","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:08:06Z","timestamp":1774044486000},"page":"722-732","source":"Crossref","is-referenced-by-count":4,"title":["A Phase 2, Randomized, Clinical Trial of Inhaled Nitric Oxide for Acute Severe Right Heart Failure With Pulmonary Hypertension (PHiNO Study)"],"prefix":"10.1253","volume":"90","author":[{"given":"Takeshi","family":"Ogo","sequence":"first","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Asano","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Takano","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fujisaki","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koko","family":"Asakura","sequence":"additional","affiliation":[{"name":"Department of Data Science, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Data Science, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Harjola VP, Mebazaa A, Celutkiene J, Bettex D, Bueno H, Chioncel O, et al. Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. <i>Eur J Heart Fail<\/i> 2016; 18: 226\u2013241, doi:10.1002\/ejhf.478.","DOI":"10.1002\/ejhf.478"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. Evaluation and management of right-sided heart failure: A scientific statement from the American Heart Association. <i>Circulation<\/i> 2018; 137: e578\u2013e622, doi:10.1161\/CIR.0000000000000560.","DOI":"10.1161\/CIR.0000000000000560"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. <i>Eur Heart J<\/i> 2022; 43: 3618\u20133731, doi:10.1093\/eurheartj\/ehac237.","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. <i>Eur Respir J<\/i> 2019; 53: 1801906, doi:10.1183\/13993003.01906-2018.","DOI":"10.1183\/13993003.01906-2018"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Suzuki S, Asano R, Aoki T, Nakayama S, Ueda J, Tsuji A, et al. Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension. <i>Open Heart<\/i> 2022; 9: e002054, doi:10.1136\/openhrt-2022-002054.","DOI":"10.1136\/openhrt-2022-002054"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Ghofrani HA, Galie N, Grimminger F, Grunig E, Humbert M, Jing ZC, et al. Riociguat for the treatment of pulmonary arterial hypertension. <i>N Engl J Med<\/i> 2013; 369: 330\u2013340, doi:10.1056\/NEJMoa1209655.","DOI":"10.1056\/NEJMoa1209655"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ghofrani HA, D\u2019Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. <i>N Engl J Med<\/i> 2013; 369: 319\u2013329, doi:10.1056\/NEJMoa1209657.","DOI":"10.1056\/NEJMoa1209657"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, et al. Selexipag for the treatment of chronic thromboembolic pulmonary hypertension. <i>Eur Respir J<\/i> 2022; 60: 2101694, doi:10.1183\/13993003.01694-2021.","DOI":"10.1183\/13993003.01694-2021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. <i>Lancet<\/i> 1991; 338: 1173\u20131174, doi:10.1016\/0140-6736(91)92033-x.","DOI":"10.1016\/0140-6736(91)92033-X"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tremblay JA, Couture EJ, Albert M, Beaubien-Souligny W, Elmi-Sarabi M, Lamarche Y, et al. Noninvasive administration of inhaled nitric oxide and its hemodynamic effects in patients with acute right ventricular dysfunction. <i>J Cardiothorac Vasc Anesth<\/i> 2019; 33: 642\u2013647, doi:10.1053\/j.jvca.2018.08.004.","DOI":"10.1053\/j.jvca.2018.08.004"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. <i>Anesthesiology<\/i> 1993; 78: 427\u2013435, doi:10.1097\/00000542-199303000-00005.","DOI":"10.1097\/00000542-199303000-00005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ichinose F, Roberts JD Jr, Zapol WM. Inhaled nitric oxide: A selective pulmonary vasodilator: Current uses and therapeutic potential. <i>Circulation<\/i> 2004; 109: 3106\u20133111, doi:10.1161\/01.CIR.0000134595.80170.62.","DOI":"10.1161\/01.CIR.0000134595.80170.62"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Kitamukai O, Sakuma M, Takahashi T, Nawata J, Ikeda J, Shirato K. Hemodynamic effects of inhaled nitric oxide using pulse delivery and continuous delivery systems in pulmonary hypertension. <i>Intern Med<\/i> 2002; 41: 429\u2013434, doi:10.2169\/internalmedicine.41.429.","DOI":"10.2169\/internalmedicine.41.429"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Perez-Penate GM, Julia-Serda G, Ojeda-Betancort N, Garcia-Quintana A, Pulido-Duque J, Rodriguez-Perez A, et al. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension. <i>J Heart Lung Transplant<\/i> 2008; 27: 1326\u20131332, doi:10.1016\/j.healun.2008.08.007.","DOI":"10.1016\/j.healun.2008.08.007"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. <i>N Engl J Med<\/i> 2005; 353: 2683\u20132695, doi:10.1056\/NEJMra051884.","DOI":"10.1056\/NEJMra051884"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. <i>Lancet<\/i> 1992; 340: 818\u2013819, doi:10.1016\/0140-6736(92)92686-a.","DOI":"10.1016\/0140-6736(92)92686-A"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Ueda J, Tsuji A, Aoki T, Asano R, Kiko T, Hayashi H, et al. Phase 2 study to evaluate the efficacy and safety of inhaled nitric oxide therapy in patients with severe right heart failure associated with pulmonary hypertension: Protocol for the PHiNO study. <i>Circ Rep<\/i> 2025; 7: 308\u2013312, doi:10.1253\/circrep.CR-24-0125.","DOI":"10.1253\/circrep.CR-24-0125"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. <i>Biometrics<\/i> 1975; 31: 103\u2013115.","DOI":"10.2307\/2529712"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. <i>Nature<\/i> 1980; 288: 373\u2013376, doi:10.1038\/288373a0.","DOI":"10.1038\/288373a0"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Hutchinson PJ, Palmer RM, Moncada S. Comparative pharmacology of EDRF and nitric oxide on vascular strips. <i>Eur J Pharmacol<\/i> 1987; 141: 445\u2013451, doi:10.1016\/0014-2999(87)90563-2.","DOI":"10.1016\/0014-2999(87)90563-2"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. <i>Br J Pharmacol<\/i> 1987; 92: 181\u2013187, doi:10.1111\/j.1476-5381.1987.tb11310.x.","DOI":"10.1111\/j.1476-5381.1987.tb11310.x"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Germann P, Braschi A, Della Rocca G, Dinh-Xuan AT, Falke K, Frostell C, et al. Inhaled nitric oxide therapy in adults: European expert recommendations. <i>Intensive Care Med<\/i> 2005; 31: 1029\u20131041, doi:10.1007\/s00134-005-2675-4.","DOI":"10.1007\/s00134-005-2675-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension: Guidelines from the American Heart Association and American Thoracic Society. <i>Circulation<\/i> 2015; 132: 2037\u20132099, doi:10.1161\/CIR.0000000000000329.","DOI":"10.1161\/CIR.0000000000000329"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Fernandes JL, Sampaio RO, Brandao CM, Accorsi TA, Cardoso LF, Spina GS, et al. Comparison of inhaled nitric oxide versus oxygen on hemodynamics in patients with mitral stenosis and severe pulmonary hypertension after mitral valve surgery. <i>Am J Cardiol<\/i> 2011; 107: 1040\u20131045, doi:10.1016\/j.amjcard.2010.11.030.","DOI":"10.1016\/j.amjcard.2010.11.030"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Matsugi E, Takashima S, Doteguchi S, Kobayashi T, Okayasu M. Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: A post-marketing study of 2817 patients in Japan. <i>Gen Thorac Cardiovasc Surg<\/i> 2024; 72: 311\u2013323, doi:10.1007\/s11748-023-01971-2.","DOI":"10.1007\/s11748-023-01971-2"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Kamenshchikov NO, Duong N, Berra L. Nitric oxide in cardiac surgery: A review article. <i>Biomedicines<\/i> 2023; 11: 1085, doi:10.3390\/biomedicines11041085.","DOI":"10.3390\/biomedicines11041085"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. <i>J Heart Lung Transplant<\/i> 2019; 38: 879\u2013901, doi:10.1016\/j.healun.2019.06.022.","DOI":"10.1016\/j.healun.2019.06.022"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/6\/90_CJ-26-0119\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:22:04Z","timestamp":1780111324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/6\/90_CJ-26-0119\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-26-0119","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"article-number":"CJ-26-0119"}}